AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2012
Feb 14, 2012
31261_dirs_2012-02-13_7add6ba5-66da-4f71-825a-2b769c983b31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: R&R ACQUISITION VI, INC (NONE)
CIK: 0001368514
Period of Report: 2012-02-13
Reporting Person: KLING ARNOLD P (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-13 | Common Stock | D | 391515 | — | Disposed | 8485 | Direct |
Footnotes
F1: On February 13, 2012, in accordance to the Agreement and Plan of Merger made and entered into as of February 13, 2012, the Reporting Person tendered to the Issuer for cancellation 391,515 shares of common stock of the Issuer beneficially owned by the Reporting Person.
More from ADMA BIOLOGICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3